Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment
ABSTRACT Background Endovascular treatment (EVT) achieves high rates of recanalization in acute large‐vessel occlusion (LVO) stroke, but functional recovery remains heterogeneous. While symptomatic intracranial hemorrhage (sICH) has been well studied, the prognostic impact of asymptomatic intracranial hemorrhage (aICH) after EVT is less certain ...
Shihai Yang +22 more
wiley +1 more source
From Inflammasomes to Pyroptosis: Molecular Mechanisms in Chronic Intestinal Diseases - Opportunity or Challenge? [PDF]
Fang J +9 more
europepmc +1 more source
Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy. [PDF]
Zhang Y +7 more
europepmc +1 more source
Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet’s Disease [PDF]
Mariko Kaji +5 more
openalex +1 more source
ABSTRACT Background Accessing brain magnetic resonance imaging (MRI) can be challenging, especially for underserved patients, which may lead to disparities in neurological diagnosis. Method This mixed‐methods study enrolled adults with one of four neurological disorders: mild cognitive impairment or dementia of the Alzheimer type, multiple sclerosis ...
Maya L. Mastick +19 more
wiley +1 more source
Research Status and Trends of Gut Microbiota and Intestinal Diseases Based on Bibliometrics. [PDF]
Sun X, Zhai J.
europepmc +1 more source
Ferroptosis as a therapeutic target for inflammation-related intestinal diseases. [PDF]
Zhang X, Ma Y, Lv G, Wang H.
europepmc +1 more source
Corrigendum to “Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes” [Parkinsonism Relat. Disord. 21(3) (2015) 231–235] [PDF]
Angelo Antonini +4 more
openalex +1 more source
Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett +8 more
wiley +1 more source

